BrainGate Clinical Trials

Partnering with leading rehabilitation centers in Boston, Chicago and Providence, Cyberkinetics is currently recruiting patients to enroll in a pilot clinical trial of the BrainGate Neural Interface System.

The BrainGate System is designed to provide a means for people with severe motor impairment a new method to communicate with a computer directly with their thoughts. As an investigational device, the BrainGate System is only offered through the clinical trial and is not commercially available.

To learn more about the Cyberkinetics’ clinical trials, please contact the designated investigator listed on the pages describing each of our clinical trials for spinal cord injury and ALS and other motor neuron disease.

Click here to see who is eligible for the US pilot study of the BrainGate System for spinal cord injury, muscular dystrophy, “locked-in syndrome” and stroke.

Click here to see who is eligible for the US pilot study of the BrainGate System for motor neuron disease, including ALS (Amyotrophic Lateral Sclerosis or Lou Gehrig’s disease).

View a BrainGate System educational animation by clicking here.